Jennifer M Wright1, Lan Deng, Paul B S Clarke. 1. Department of Pharmacology and Therapeutics, McGill University, McIntyre Medical Building Rm. 1320, 3655 Promenade Sir William Osler, Montreal, QC H3G 1Y6, Canada.
Abstract
RATIONALE: Frequency-modulated 50-kHz ultrasonic vocalizations (USVs) are emitted by adult rats in response to psychostimulants and non-pharmacological appetitive stimuli and thus have been proposed to model positive affect. OBJECTIVE: The main aim was to determine whether rewarding doses of morphine increase 50-kHz call rate or alter the relative prevalence of the trill call subtype. METHODS: In experiment 1, USVs were recorded from adult male Long-Evans rats after subchronic morphine (1 mg/kg subcutaneous (SC)) administration, acute challenge with morphine (1 and 3 mg/kg SC) or amphetamine (1 mg/kg IP, positive control), and in conjunction with locomotor activity tests with morphine (1 and 3 mg/kg SC). In experiments 2 and 3, the USV altering, rewarding, and locomotor effects of morphine were examined using a conditioned place preference (CPP) procedure. RESULTS: In experiment 1, morphine (1 mg/kg) initially suppressed calling; rats became tolerant to this effect with repeated exposure. Tested subsequently in singly- and pair-tested rats, morphine markedly decreased USVs but significantly increased locomotor activity. In experiments 2 and 3, morphine produced a significant CPP without increasing either unconditioned or conditioned USV emission. Morphine did not detectably alter the relative prevalence of 50-kHz call subtypes. CONCLUSIONS: Although 50-kHz calls, and the trill call subtype in particular, have been proposed as an animal model of positive mood, not all euphoriant drugs acutely increase the rate of 50-kHz calling or consistently promote trill calls.
RATIONALE: Frequency-modulated 50-kHz ultrasonic vocalizations (USVs) are emitted by adult rats in response to psychostimulants and non-pharmacological appetitive stimuli and thus have been proposed to model positive affect. OBJECTIVE: The main aim was to determine whether rewarding doses of morphine increase 50-kHz call rate or alter the relative prevalence of the trill call subtype. METHODS: In experiment 1, USVs were recorded from adult male Long-Evans rats after subchronic morphine (1 mg/kg subcutaneous (SC)) administration, acute challenge with morphine (1 and 3 mg/kg SC) or amphetamine (1 mg/kg IP, positive control), and in conjunction with locomotor activity tests with morphine (1 and 3 mg/kg SC). In experiments 2 and 3, the USV altering, rewarding, and locomotor effects of morphine were examined using a conditioned place preference (CPP) procedure. RESULTS: In experiment 1, morphine (1 mg/kg) initially suppressed calling; rats became tolerant to this effect with repeated exposure. Tested subsequently in singly- and pair-tested rats, morphine markedly decreased USVs but significantly increased locomotor activity. In experiments 2 and 3, morphine produced a significant CPP without increasing either unconditioned or conditioned USV emission. Morphine did not detectably alter the relative prevalence of 50-kHz call subtypes. CONCLUSIONS: Although 50-kHz calls, and the trill call subtype in particular, have been proposed as an animal model of positive mood, not all euphoriant drugs acutely increase the rate of 50-kHz calling or consistently promote trill calls.
Authors: Esther Y Maier; Allison M Ahrens; Sean T Ma; Timothy Schallert; Christine L Duvauchelle Journal: Behav Brain Res Date: 2010-05-12 Impact factor: 3.332
Authors: Adam Hamed; Ewa Taracha; Janusz Szyndler; Paweł Krząścik; Małgorzata Lehner; Piotr Maciejak; Anna Skórzewska; Adam Płaźnik Journal: Behav Brain Res Date: 2012-02-06 Impact factor: 3.332
Authors: David J Barker; Steven J Simmons; Lisa C Servilio; Danielle Bercovicz; Sisi Ma; David H Root; Anthony P Pawlak; Mark O West Journal: Psychopharmacology (Berl) Date: 2013-11-07 Impact factor: 4.530
Authors: David J Barker; Danielle Bercovicz; Lisa C Servilio; Steven J Simmons; Sisi Ma; David H Root; Anthony P Pawlak; Mark O West Journal: Addict Biol Date: 2013-03-18 Impact factor: 4.280